OcuRing™ (Anti-inflammatory)
Post-cataract surgery inflammation and pain
Key Facts
About LayerBio
LayerBio is an ophthalmic drug delivery company pioneering a novel, bioerodible sustained-release technology called OcuRing™. The platform is engineered to integrate with any standard intraocular lens (IOL) implanted during cataract surgery, aiming to provide localized, long-term delivery of therapeutics to the anterior and posterior segments of the eye. This approach targets a significant unmet need for effective post-surgical management of inflammation and pain, and potentially chronic conditions like glaucoma or macular edema, without requiring additional injections or patient compliance. As a private, preclinical-stage entity, the company is positioned to capitalize on the massive and growing cataract surgery market by enhancing the standard-of-care procedure with a built-in therapeutic delivery mechanism.
View full company profile